Levosimendan for the treatment of acute heart failure syndromes

Author： Parissis John T   Filippatos Gerasimos   Farmakis Dimitrios   Adamopoulos Stamatis   Paraskevaidis Ioannis   Kremastinos Dimitrios  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.15, 2005-12, pp. : 2741-2751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levosimendan: A Review of its Use in the Management of Acute Decompensated Heart Failure

By Innes C.A.   Wagstaff A.J.  

Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. : 2651-2671

Adis International

Access to resources Recommend Favorite

Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure

By  

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 435-455

Bentham Science Publishers

Access to resources Recommend Favorite

Levosimendan a reviving choice in heart failure

By  

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

The Extended Role of the Clinical Pharmacist in the Management of Heart Failure and Acute Coronary Syndromes

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 1, 2002-03 ,pp. : 17-23

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Investigational Drugs for the Management of Acute Heart Failure Syndromes

By  

Current Medicinal Chemistry, Vol. 17, Iss. 4, 2010-02 ,pp. : 363-390

Bentham Science Publishers

Access to resources Recommend Favorite